It has previously been hypothesized that the outcome of loss-of-function PRKN mutations are highly cell-context dependent; the increased half-life of cyclins leads to cancer in mitotically competent cells while the same cyclins may promote apoptosis upon cell cycle reentry in post-mitotic cells, such as neurons57,61–64. Here, PRKN is linked to cancer.